Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,039Revenue $M2,595Net Margin (%)6.7Z-Score7.0
Enterprise Value $M5,584EPS $3.2Operating Margin %8.1F-Score5
P/E(ttm))34.1Cash Flow Per Share $4.5Pre-tax Margin (%)8.2Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %3.8Quick Ratio2.7Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %10.5Current Ratio2.8Lower Leverage y-yN
Price/Cash Flow13.0y-y EBITDA Growth Rate %3.4ROA % (ttm)7.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M56.6ROI % (ttm)9.6Gross Margin Increase y-yY

Gurus Latest Trades with CVD

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVDJoel Greenblatt 2014-09-30 Add0.23%$80.49 - $88.98
($85.03)
$ 106.7226%Add 82.66%650,283
CVDKen Fisher 2014-09-30 Add$80.49 - $88.98
($85.03)
$ 106.7226%Add 52.32%39,027
CVDRay Dalio 2014-09-30 Buy $80.49 - $88.98
($85.03)
$ 106.7226%New holding, 6437 sh.6,437
CVDJoel Greenblatt 2014-06-30 Add0.37%$81.55 - $106.04
($89.16)
$ 106.7220%Add 2662.77%356,011
CVDKen Fisher 2014-06-30 Buy $81.55 - $106.04
($89.16)
$ 106.7220%New holding, 25621 sh.25,621
CVDJoel Greenblatt 2014-03-31 Add0.01%$86.85 - $105.69
($98.65)
$ 106.728%Add 33.96%12,886
CVDJoel Greenblatt 2013-12-31 Buy 0.02%$83.45 - $90.51
($86.53)
$ 106.7223%New holding, 9619 sh.9,619
CVDVanguard Health Care Fund 2013-06-30 Add0.48%$71.21 - $78.88
($74.79)
$ 106.7243%Add 317.31%2,246,400
CVDVanguard Health Care Fund 2013-03-31 Buy 0.16%$57.77 - $74.32
($67.12)
$ 106.7259%New holding, 538300 sh.538,300
CVDJames Barrow 2012-09-30 Buy 0.07%$46.39 - $49.24
($47.79)
$ 106.72123%New holding, 785725 sh.785,725
CVDJoel Greenblatt 2012-09-30 Sold Out -0.13%$46.39 - $49.24
($47.79)
$ 106.72123%Sold Out0
CVDJoel Greenblatt 2012-06-30 Add0.05%$44.42 - $47.81
($46.14)
$ 106.72131%Add 53.73%38,072
CVDRon Baron 2012-03-31 Reduce-0.09%$43.31 - $49.24
($43.49)
$ 106.72145%Reduce -50%300,000
CVDJoel Greenblatt 2011-12-31 Add0.03%$43.43 - $52.9
($46.97)
$ 106.72127%Add 23.51%26,917
CVDRay Dalio 2011-12-31 Sold Out -0.03%$43.43 - $52.9
($46.97)
$ 106.72127%Sold Out0
CVDJoel Greenblatt 2011-09-30 Add0.1%$44.79 - $62.26
($52.92)
$ 106.72102%Add 143.35%21,794
CVDRay Dalio 2011-09-30 Buy 0.03%$44.79 - $62.26
($52.74)
$ 106.72102%New holding, 45737 sh.45,737
CVDGeorge Soros 2011-06-30 Sold Out $55.92 - $62.6
($59.15)
$ 106.7280%Sold Out0
CVDJoel Greenblatt 2011-06-30 Reduce-0.25%$55.92 - $62.6
($59.15)
$ 106.7280%Reduce -63.28%8,956
CVDJoel Greenblatt 2011-03-31 Add0.29%$50.31 - $58.8
($55.18)
$ 106.7293%Add 249.98%24,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVD Ray Dalio 2014-09-306,4370.010New Buy
CVD Joel Greenblatt 2014-09-30650,2831.150.51+82.66%
CVD Ken Fisher 2014-09-3039,0270.070.01+52.32%
CVD Ron Baron 2014-09-30300,0000.530.1
CVD Vanguard Health Care Fund 2014-09-302,486,0004.390.5
CVD James Barrow 2014-09-30681,3201.20.07-2.9%
Premium Most recent portfolio changes are included for Premium Members only!


CVD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NUTT BRIAN H.Principal Accounting Officer 2014-12-22Sell1,127$103.513.1view
HERRING JOSEPH LChairman and CEO 2014-12-18Sell32,692$103.023.59view
WATSON JOHN E.Corp. Sr. Vice President 2014-12-10Sell15,200$102.943.67view
Cimino Richard FCorp. Executive Vice President 2014-12-05Sell20,240$103.163.45view
Cornell Alison ACorporate Senior VP and CFO 2014-12-05Sell17,570$103.233.38view
WATSON JOHN E.Corp. Sr. Vice President 2014-12-05Sell14,500$103.213.4view
Keller Deborah LCorp. Executive Vice President 2014-12-05Sell17,770$103.133.48view
HERRING JOSEPH LChairman and CEO 2014-09-09Sell32,200$85.1325.36view
NUTT BRIAN H.Principal Accounting Officer 2014-02-25Sell210$103.223.39view
KLITGAARD WILLIAM ECorporate Sr. Vice President 2014-02-20Sell25,778$101.84.83view

Press Releases about CVD :

    Quarterly/Annual Reports about CVD:

    News about CVD:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    Covance Inc. Reports Operating Results (10-K) Feb 28 2011 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 13,000 Shares Dec 21 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 31,300 Shares Dec 15 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 19,305 Shares Nov 22 2010 
    Weekly Guru Bargains Highlights: SD, CREE, AMLN, ICLR, CVD Nov 07 2010 
    Covance Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Weekly Guru Bargains Highlights: Whirlpool Corp, Plexus Corp, Pulte Homes Inc, Owens Corning, Covanc Sep 18 2010 
    Weekly CEO Buys Highlight: Dynex Capital Inc, Helix Energy Solutions Group Inc, Superior Energy Serv Aug 08 2010 

    More From Other Websites
    LabCorp raising $2.9 billion to help fund Covance purchase Jan 22 2015
    Covance Launches New Solution to Bridge Preclinical to Clinical Development Jan 20 2015
    Covance Launches New Solution to Bridge Preclinical to Clinical Development Jan 20 2015
    Quintiles chief looks to grab market share with LabCorp-Covance deal Jan 15 2015
    COVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 12 2015
    Covance Sets February 18, 2015 As Date of Special Stockholder Meeting To Vote On Its Proposed... Jan 12 2015
    Covance Sets February 18, 2015 As Date of Special Stockholder Meeting To Vote On Its Proposed... Jan 12 2015
    Here's what analysts think about LabCorp ahead of Covance merger Jan 08 2015
    LabCorp, Covance tap Deloitte to help with merger Jan 06 2015
    How Can We Encourage Participation in Clinical Trials? Jan 06 2015
    Recent IPO PRA Health Sciences Finds Growth In Buyout Dec 30 2014
    13 primates die at South Texas research facility Dec 22 2014
    13 primates die at South Texas research facility Dec 22 2014
    Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance Dec 16 2014
    Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance Dec 16 2014
    COVANCE INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Dec 12 2014
    Investor Lawsuit Against Takeover of Covance Inc. (CVD) Announced by Shareholders Foundation Dec 08 2014
    Watch Out: Barbarians At The Gate For Covance (CVD) Nov 28 2014
    Morgan & Morgan Announces That It is Investigating the Sale of Covance, Inc. ? CVD Nov 20 2014
    Covance (CVD) Sellout Decision to LabCorp: A Strategic Fit? Nov 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK